Outcome of Zeiss AT LARA EDOF Lens Implantation in Vitrectomized Eyes (LARA)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The surgical outcome is defined as the patient satisfaction determined by patient questionnaires.
- Visual quality: CatQuest questionnaire
- Near vision: NAVS questionnaire
- Glare: APPLES questionnaire
These questionnaires are standardized and validated, although no cut-off values have been determined. Hence, the results drawn from these questionnaires are descriptive only.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients that had a LARA IOL implanted in combination with vitrectomy.
- patients that had a LARA IOL implanted in during surgery for cataract secondary to vitrectomy.
Exclusion Criteria:
- Patients with a LARA IOL implanted without concomitant or earlier vitrectomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: group 1: LARA IOL implanted in combination with vitrectomy.
intraocular lens implantation in combination with vitrectomy
|
Lens surgery during or before vitrectomy surgery.
|
|
Active Comparator: group 2: LARA IOL implanted in during surgery for cataract secondary to vitrectomy
intraocular lens implantation during surgery for cataract secondary to vitrectomy
|
Lens surgery during or before vitrectomy surgery.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
visual quality
Time Frame: 2 weeks
|
Catquest questionnaire measuring activity limitations in daily life due to poor vision
|
2 weeks
|
|
near vision
Time Frame: 2 weeks
|
Near Activity Visual Questionnaire (NAVQ) evaluating the near vision
|
2 weeks
|
|
glare
Time Frame: 2 weeks
|
The Assessment of Photic Phenomena and Lens Effects (APPLES) questionnaire assessing the glare
|
2 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Binocular performance
Time Frame: 2 weeks
|
visual acuity
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- S65356
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.